GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2499.75 and 2555.65
| Intraday Target 1 | 2484.9 |
| Intraday Target 2 | 2514.6 |
| Intraday Target 3 | 2540.8 |
| Intraday Target 4 | 2570.5 |
| Intraday Target 5 | 2596.7 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 08 December 2025 | 2544.30 (-0.05%) | 2545.60 | 2511.10 - 2567.00 | 0.8355 times | Fri 05 December 2025 | 2545.60 (1.39%) | 2492.00 | 2491.20 - 2582.50 | 1.7491 times | Thu 04 December 2025 | 2510.80 (-0.32%) | 2520.00 | 2494.90 - 2539.00 | 0.9085 times | Wed 03 December 2025 | 2518.90 (-0.03%) | 2512.00 | 2461.10 - 2529.90 | 1.3089 times | Tue 02 December 2025 | 2519.60 (0.97%) | 2495.60 | 2482.00 - 2525.50 | 0.8855 times | Mon 01 December 2025 | 2495.40 (-2.88%) | 2551.00 | 2490.00 - 2558.50 | 0.9905 times | Fri 28 November 2025 | 2569.50 (1.98%) | 2519.60 | 2479.00 - 2585.10 | 1.2156 times | Thu 27 November 2025 | 2519.60 (1.22%) | 2489.70 | 2465.10 - 2524.40 | 0.4858 times | Wed 26 November 2025 | 2489.30 (0.13%) | 2483.00 | 2459.70 - 2509.90 | 0.723 times | Tue 25 November 2025 | 2486.10 (0.37%) | 2477.00 | 2430.00 - 2499.00 | 0.8974 times | Mon 24 November 2025 | 2477.00 (-0.84%) | 2497.90 | 2404.20 - 2497.90 | 1.4042 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2499.75 and 2555.65
| Weekly Target 1 | 2484.9 |
| Weekly Target 2 | 2514.6 |
| Weekly Target 3 | 2540.8 |
| Weekly Target 4 | 2570.5 |
| Weekly Target 5 | 2596.7 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 08 December 2025 | 2544.30 (-0.05%) | 2545.60 | 2511.10 - 2567.00 | 0.2119 times | Fri 05 December 2025 | 2545.60 (-0.93%) | 2551.00 | 2461.10 - 2582.50 | 1.4816 times | Fri 28 November 2025 | 2569.50 (2.87%) | 2497.90 | 2404.20 - 2585.10 | 1.1985 times | Fri 21 November 2025 | 2497.90 (0.75%) | 2491.70 | 2471.40 - 2532.60 | 1.1162 times | Fri 14 November 2025 | 2479.40 (-4.19%) | 2587.00 | 2467.50 - 2590.60 | 1.5378 times | Fri 07 November 2025 | 2587.90 (-1.17%) | 2644.00 | 2479.00 - 2694.00 | 1.3415 times | Fri 31 October 2025 | 2618.60 (-5.06%) | 2760.00 | 2601.00 - 2760.00 | 1.0918 times | Fri 24 October 2025 | 2758.10 (0.55%) | 2739.00 | 2716.10 - 2795.90 | 0.427 times | Fri 17 October 2025 | 2742.90 (-0.89%) | 2753.60 | 2708.40 - 2780.00 | 0.6745 times | Fri 10 October 2025 | 2767.40 (0.79%) | 2754.00 | 2698.00 - 2782.40 | 0.9192 times | Fri 03 October 2025 | 2745.80 (2.75%) | 2669.90 | 2622.60 - 2759.90 | 0.6733 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2442 and 2563.4
| Monthly Target 1 | 2407.9 |
| Monthly Target 2 | 2476.1 |
| Monthly Target 3 | 2529.3 |
| Monthly Target 4 | 2597.5 |
| Monthly Target 5 | 2650.7 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 08 December 2025 | 2544.30 (-0.98%) | 2551.00 | 2461.10 - 2582.50 | 0.2299 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 0.705 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.4578 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 0.7292 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.0092 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 0.6162 times | Mon 30 June 2025 | 3388.10 (2.71%) | 3298.00 | 3153.90 - 3515.70 | 1.2328 times | Fri 30 May 2025 | 3298.60 (11.27%) | 2935.30 | 2693.90 - 3398.00 | 2.2138 times | Wed 30 April 2025 | 2964.60 (2.92%) | 2872.00 | 2401.00 - 3148.00 | 1.6551 times | Fri 28 March 2025 | 2880.35 (16.36%) | 2485.00 | 2390.05 - 2988.00 | 1.151 times | Fri 28 February 2025 | 2475.35 (25.2%) | 1955.95 | 1921.00 - 2744.95 | 6.1855 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2232.65 and 3827.35
| Yearly Target 1 | 1065.63 |
| Yearly Target 2 | 1804.97 |
| Yearly Target 3 | 2660.3333333333 |
| Yearly Target 4 | 3399.67 |
| Yearly Target 5 | 4255.03 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 08 December 2025 | 2544.30 (12.99%) | 2235.00 | 1921.00 - 3515.70 | 2.609 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2972 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.277 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7417 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9894 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.1041 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4723 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2402 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1343 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1346 times | Thu 31 December 2015 | 3294.85 (0%) | 3347.95 | 3077.00 - 3435.00 | 0.0313 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in downtrend.
But this trend seems to be weakening.Price is above an important level of 2524.99 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Munafa value: 50 as on Mon 08 December 2025
This Munafa value indicates that the stock is moving sideways and there is no definite momentum in the stock.
SMA20 is at 2507 and price is deviating by 25 points
Upper Bollinger band is at 2556 and lower is at 2459, while middle bands are at 2483 and 2532
Price is coming down
Price is above 20day SMA
Price is in upper range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for GlaxosmithklinePharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
GlaxosmithklinePharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for GlaxosmithklinePharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2523.79 and GlaxosmithklinePharmaceuticals GLAXO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2527.84 |
| 12 day DMA | 2514.5 |
| 20 day DMA | 2507 |
| 35 day DMA | 2577.39 |
| 50 day DMA | 2621.78 |
| 100 day DMA | 2746.97 |
| 150 day DMA | 2887.45 |
| 200 day DMA | 2847.48 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2531.52 | 2525.13 | 2514.9 |
| 12 day EMA | 2524.99 | 2521.48 | 2517.1 |
| 20 day EMA | 2535.9 | 2535.02 | 2533.91 |
| 35 day EMA | 2573.87 | 2575.61 | 2577.38 |
| 50 day EMA | 2623.34 | 2626.56 | 2629.86 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2527.84 | 2518.06 | 2522.84 |
| 12 day SMA | 2514.5 | 2511.56 | 2509.34 |
| 20 day SMA | 2507 | 2506.77 | 2508.89 |
| 35 day SMA | 2577.39 | 2582.52 | 2587.95 |
| 50 day SMA | 2621.78 | 2625.82 | 2630.15 |
| 100 day SMA | 2746.97 | 2753.41 | 2760.39 |
| 150 day SMA | 2887.45 | 2889.79 | 2891.83 |
| 200 day SMA | 2847.48 | 2844.75 | 2842.18 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 56.09 and PE is: 45.36
Last quarter profit: (June 2025 quarter) 205.01 crores (12.44%)
Debt: 9.95 in crores
Market capitalization: 47197.61
EPS is 54.75 and PE is: 46.47
Last quarter profit: (March 2025 quarter) 262.87 crores (36.37%)
Debt: 9.95 in crores
Market capitalization: 55880.27
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance


